Scand J Immunol
April 2022
Introduction: For many patients with primary immune deficiency (PID), stem-cell transplantation (SCT) may be life-saving.
Objective: To review our experience of 11 years transplanting children with PID in Mexico.
Methods: Chart review of patients who underwent SCT from 2008 to 2018, to describe their diagnoses, time to transplant, conditioning regime, survival rate and outcomes.